Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage | Zendy

Stacey W. Martin | Zendy; Lucia C. Pawloski | Zendy; Margaret M. Williams | Zendy; K. Weening | Zendy; Chas DeBolt | Zendy; Xuan Qin | Zendy; Laura Reynolds | Zendy; C. Kenyon | Zendy; G. P. Giambrone | Zendy; Kathy Kudish | Zendy; Lisa A. Miller | Zendy; David Selvage | Zendy; Arier Lee | Zendy; Tami H. Skoff | Zendy; Hajime Kamiya | Zendy; Pamela K. Cassiday | Zendy; M. Lucia Tondella | Zendy; Thomas A. Clark | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage

Author(s) -

Stacey W. Martin,

Lucia C. Pawloski,

Margaret M. Williams,

K. Weening,

Chas DeBolt,

Xuan Qin,

Laura Reynolds,

C. Kenyon,

G. P. Giambrone,

Kathy Kudish,

Lisa A. Miller,

David Selvage,

Arier Lee,

Tami H. Skoff,

Hajime Kamiya,

Pamela K. Cassiday,

M. Lucia Tondella,

Thomas A. Clark

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu788

Subject(s) - pertactin , bordetella pertussis , medicine , pertussis vaccine , immunology , immunization , bacteria , biology , pertussis toxin , genetics , antigen , g protein , receptor

A recent increase in Bordetella pertussis without the pertactin protein, an acellular vaccine immunogen, has been reported in the United States. Determining whether pertactin-deficient (PRN(-)) B. pertussis is evading vaccine-induced immunity or altering the severity of illness is needed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research